Ignite Creation Date:
2025-12-25 @ 2:52 AM
Ignite Modification Date:
2025-12-30 @ 7:18 AM
Study NCT ID:
NCT00035633
Status:
COMPLETED
Last Update Posted:
2011-04-14
First Post:
2002-05-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-12
Start Date Type:
None
Primary Completion Date:
2005-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-02
Completion Date Type:
ACTUAL
First Submit Date:
2002-05-04
First Submit QC Date:
None
Study First Post Date:
2002-05-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2010-02-01
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2011-04-07
Last Update Post Date:
2011-04-14
Last Update Post Date Type:
ESTIMATED